Warrior (HCC): Q3 2026 Earnings
Warrior Met Coal’s Blue Creek mine cut costs to about $93 a ton, offsetting a wider discount for High Vol A coking coal as US supply expands.
Warrior Met Coal’s Blue Creek mine cut costs to about $93 a ton, offsetting a wider discount for High Vol A coking coal as US supply expands.
$BOOT is taking up store adds by 10-15% for '27, but is taking DOWN revenue forecast. Can anyone with half a brain convince me that this is a positive development? Never ends well...
You heard it here first... what a huge earnings beat for $PBI "Specifically, we added more than 30 new clients, representing an estimated two billion pieces of annual volume, as a result of this exit" https://t.co/uyMhmLTrHi
$GEN might actually be a pretty good business https://t.co/5dQEvZFVwa https://t.co/ewNvBnvYV7
$CVNA looks like it's sacrificing loan monetization to drive units. This is a very slippery slope my friends. We've been short this, and 100% wrong, to be transparent and accountable. But the fundamental story looks like its starting to show signs of erosion on the margin.
whoops $NOW $FTNT,........ guess that run up in software names past few weeks was fundamentally driven huh? Flows mean nothing in this market anymore, it's liquidity AI on or off. Do your own work if a narrative is actually working or not and take a timeline beyond 3 days
@essential6t7 @ChopraUSA Buyside more focused on $WU taken over by now. Was said they launched sale process post-bid. Think market still underestimating buyout odds, add to that high SI.
@mario_cibelli Not for $WU: decline comes from price cuts & higher commissions, which flow straight to profit. If future losses come from vol instead, much of hit offset by lower variable commissions. Plus H2 cost cuts puts break-even beyond 8–9%. write-down unlikely, bc GW tested with digital.
Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…
L3Harris booked $19.3 billion of Q3 orders, lifting backlog to $53.2 billion, raised FY26 guidance and cut its 2028 free-cash-flow target…
Oracle’s CDS spreads exceed 320 basis points as debt approaches $135 billion and fiscal 2027 capex targets $95 billion, amid heavy reliance…
Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…
Coupang’s product-commerce growth rose 9% as data-leak effects fade, while management expects margins to return to pre-incident levels by…
David Orr describes running Militia Capital’s roughly 500-stock long-short portfolio, using expected value, correlation and factor…
Coupang expects Product Commerce margins to return to pre-data incident levels by mid-2027 as customer spending recovers and Taiwan…
Novo Nordisk beat Q3 consensus as Wegovy pill sales reached DKK 5.4bn, raised 2026 guidance again and reported DKK 79.2bn revenue.
Shopify's 3Q 2026 GMV grew 30% FX-neutral, reaching 46% of Amazon retail GMV after merchants captured nearly half of incremental U.S.
Gartner’s growth has stalled after federal contract losses and cautious commercial spending, raising questions about its competitive…
Used aircraft engines can be repurposed as gas turbines, easing data center power constraints while tightening aviation supply.
Intel’s 30% stock collapse followed guidance for a more than 20% sequential Q4 client revenue decline, server CPU packaging constraints and…
Chipotle plans 350 to 400 annual openings and low single-digit same-store sales growth, supported by menu innovation, international…
AMRZ · long Amrize (AMRZ) produces aggregates, cement and roofing materials across the US and Canada.
Builders FirstSource's buybacks halved its share count since 2021, while 4.1x leverage, fixed-rate debt and post-2030 maturities support it…
Twilio's Q3 revenue rose 20% to $1.56 billion, but Q4 organic growth guidance fell to 11% to 12% and RPO declined 28%.
Merck reported Q3 revenue of $18.1 billion, up 5%, and raised 2026 guidance as Keytruda sales reached $8.6 billion ahead of its 2028 patent…
Incyte reported Q3 revenue of $1.56 billion, up 14%, as Opzelura sales rose 36%; a $1.23 billion Vega acquisition charge drove an operating…
Marvell and Lumentum’s merger targets uVCSEL scale-in optics, combining Marvell’s DSP and analog IP with Lumentum’s laser manufacturing for…
Stevanato fell 30% after forecasting low-single-digit 2027 growth as lower Nexa syringe volumes from a GLP-1 customer offset solid Q3…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.